Literature DB >> 35213945

Increasing COVID-19 vaccine acceptance among the general population while maintaining autonomy.

Dorcas Serwaa1, Emmanuel Lamptey1, Ephraim Kumi Senkyire2.   

Abstract

The accelerated dissemination of coronavirus disease, its effects on the general public and healthcare system have been unparalleled. COVID-19 vaccination is critical for reducing the alarming incidence of the infection, promoting herd immunity, preventing associated mortality and morbidity, and maintaining public health and safety. Through the development of COVID-19 vaccines, many people are keen to protect themselves against the virus; however, the willingness for vaccination especially in Africa, is far below what is required to stop the ongoing COVID-19 pandemic. As a result, there is an immediate need to implement plans aimed at increasing population vaccine willingness. The slippery slope is whether sanctions, bans and restriction should be imposed on hesitant persons, since transmission of the epidemic can be prevented through stringent enforcement of the control barriers, while eradicating the disease would necessitate vaccination. This commentary provides recommendations about how to increase population vaccine acceptance while maintaining autonomy.

Entities:  

Keywords:  Autonomy; COVID-19; vaccination; vaccine acceptance; vaccine hesitancy

Mesh:

Substances:

Year:  2021        PMID: 35213945      PMCID: PMC8903969          DOI: 10.1080/21645515.2021.1922265

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  15 in total

1.  The architecture of provider-parent vaccine discussions at health supervision visits.

Authors:  Douglas J Opel; John Heritage; James A Taylor; Rita Mangione-Smith; Halle Showalter Salas; Victoria Devere; Chuan Zhou; Jeffrey D Robinson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

2.  Attitudes and beliefs of healthcare workers about influenza vaccination.

Authors:  Carmel Halpin; Bernie Reid
Journal:  Nurs Older People       Date:  2019-03-22

3.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

4.  Travel restrictions as a disease control measure: Lessons from yellow fever.

Authors:  Samantha Vanderslott; Tatjana Marks
Journal:  Glob Public Health       Date:  2020-08-10

5.  Factors in vaccination intention against the pandemic influenza A/H1N1.

Authors:  Michel Setbon; Jocelyn Raude
Journal:  Eur J Public Health       Date:  2010-05-05       Impact factor: 3.367

6.  How did we get here? Short history of COVID-19 and other coronavirus-related epidemics.

Authors:  Miriam N Lango
Journal:  Head Neck       Date:  2020-05-23       Impact factor: 3.147

7.  The Impact of COVID-19 on Pediatric Vaccination Rates in Alabama.

Authors:  Hannah E Brooks; Lane A McLendon; Casey L Daniel
Journal:  Prev Med Rep       Date:  2021-02-05

Review 8.  Modeling infectious disease dynamics in the complex landscape of global health.

Authors:  Hans Heesterbeek; Roy M Anderson; Viggo Andreasen; Shweta Bansal; Daniela De Angelis; Chris Dye; Ken T D Eames; W John Edmunds; Simon D W Frost; Sebastian Funk; T Deirdre Hollingsworth; Thomas House; Valerie Isham; Petra Klepac; Justin Lessler; James O Lloyd-Smith; C Jessica E Metcalf; Denis Mollison; Lorenzo Pellis; Juliet R C Pulliam; Mick G Roberts; Cecile Viboud
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

9.  Measuring trust in vaccination: A systematic review.

Authors:  Heidi J Larson; Richard M Clarke; Caitlin Jarrett; Elisabeth Eckersberger; Zachary Levine; Will S Schulz; Pauline Paterson
Journal:  Hum Vaccin Immunother       Date:  2018-05-10       Impact factor: 3.452

10.  Characteristics of Household Transmission of COVID-19.

Authors:  Wei Li; Bo Zhang; Jianhua Lu; Shihua Liu; Zhiqiang Chang; Cao Peng; Xinghua Liu; Peng Zhang; Yan Ling; Kaixiong Tao; Jianying Chen
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.